APA (7th ed.) Citation

Faiella, M., Botti, G., Dalpiaz, A., Gnudi, L., Goyenvalle, A., Pavan, B., . . . Marchesi, E. (2024). In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment. Pharmaceutics, 16(8), 1023. https://doi.org/10.3390/pharmaceutics16081023

Chicago Style (17th ed.) Citation

Faiella, Marika, Giada Botti, Alessandro Dalpiaz, Lorenzo Gnudi, Aurélie Goyenvalle, Barbara Pavan, Daniela Perrone, Matteo Bovolenta, and Elena Marchesi. "In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment." Pharmaceutics 16, no. 8 (2024): 1023. https://doi.org/10.3390/pharmaceutics16081023.

MLA (9th ed.) Citation

Faiella, Marika, et al. "In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment." Pharmaceutics, vol. 16, no. 8, 2024, p. 1023, https://doi.org/10.3390/pharmaceutics16081023.